Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
regeneron pharmaceuticals
2
×
san francisco blog main
san francisco top stories
age related macular degeneration
agios pharmaceuticals
american society of hematology
amgen
beta-thalassemia
blood diseases
bluebird bio
bortezomib
boulder/denver blog main
boulder/denver top stories
cancer
cemiplimab
cholesterol
cooley's anemia foundation
craig butler
data
detroit blog main
detroit top stories
diffuse large b-cell lymphoma
drugs
fda
follicular lymphoma
gene therapy
geoffrey porges
global blood therapeutics
ibrutinib
imbruvica
inclisiran
indiana blog main
What
big
2
×
week
aces
american
announced
ash
blood
ceo
cholesterol
country
diego
disease
drug
flexible
gathering
hematology’s
inclisiran
key
largest
lowering
meant
medco
medical
medicine
medicines
meeting
nasdaq
open
passed
previewed
pricing
rolls
san
society
taken
test
twice
xconomy
year
Language
unset
Current search:
big
×
" regeneron pharmaceuticals "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
